Google News – The Financial

Periodontal Therapeutics Market to Undertake Strapping Growth by the End 2024

June 14, 2018 - by Nitin

The global Periodontal Therapeutics Market is highly consolidated in nature on account of a few players holding most of the share in the market. Some of the key players in the market are Den-Mat Holdings, Valeant Pharmaceuticals international, Inc., 3M, Galderma S.A., and LLC Dexcel Pharma. In 2015, 3M, Valeant Pharmaceuticals Int. Inc., and Den-Mat Holdings emerged as the top three players in the market and together they accounted for a mammoth share of 77.7%. A key trend noticed in the global market for periodontal therapeutics is the investment into research and development of more effective therapies by prominent participants. …

Google News / Healthcare

Parkinson’s Disease Therapeutics Market to Observe Strong Development by 2025

June 14, 2018 - by Nitin

The global Parkinson’s Disease Therapeutics Market was valued at US$ 2.18 Bn in 2016 and is projected to register a cumulative annual growth rate (CAGR) of more than 10.9% from 2017 to 2025, according to a new report titled “Parkinson’s Disease Threapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025” published by Transparency Market Research (TMR) (. The report states that high prevalence of Parkinson’s disease, rise in geriatric population across the globe, increase in funding for clinical research and grants, etc. are expected to spur the growth of the Parkinson’s disease therapeutic drugs during the …

Google News / Healthcare

Collagen Peptide and Gelatin Market Progresses for Huge Profits by the End 2025

June 14, 2018 - by Nitin

As per the assessment of Transparency Market Research, some of the main players operating in the global Collagen Peptide And Gelatin Market include GELITA AG, Catalent, Inc., Rousselot, Nitta Gelatin, Inc., Capsugel Belgium NV and Amicogen, Inc. As far as GELITA AG is concerned, the company is focused on undertaking a robust research and development in order to develop gelatin and collagen peptides that are used in various kinds of industries like food and beverage, pharmaceuticals and nutraceuticals. In addition, the company also manufactures tailor-made products as per the demand of the customers. In order to get an edge over …

Google News / Healthcare

Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Projected to Garner Significant Revenues by 2025

June 14, 2018 - by Nitin

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market was valued at approximately US$ 2.9 Bn in 2016 is projected to register cumulative annual growth rate (CAGR) of over 3.2% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. The report suggests that rising incidence of the development of antibiotic resistant strains among all age groups are likely to spur the demand of MRSA Drugs in the coming years (2017 to 2025). As key players introduce novel anti-MRSA …

Google News / Healthcare

Thyroid Gland Disorders Treatment Market Estimated to Expand at a Robust CAGR by 2025

June 14, 2018 - by Nitin

The global Thyroid Gland Disorders Treatment Market features a consolidated vendor landscape with a handful of companies accounting for a major chunk of the global market, observes Transparency Market Research in a recent report. In 2016, the thyroid gland disorders treatment market was dominated by Merck KGaA and AbbVie, Inc., which collectively accounted for more than half of the market. It has been observed that despite the large pool of thyroid gland disorder patients across the globe, preference to alternative treatment methods brings down the growth prospects of companies operating in the market. Nevertheless, with innovative marketing strategies and attempts …

Google News / Healthcare

Sterile Injectable Drugs Market Pegged for Robust Expansion by 2025

June 14, 2018 - by Nitin

The global Sterile Injectable Drugs Market has been envisioned by Transparency Market Research (TMR) to hold a significantly concentrated nature for its vendor landscape. In a new report by TMR, some of the important players of the market have been profiled by the analysts, including AstraZeneca, GlaxoSmithKline plc, Pfizer Inc., Sanofi, and Baxter International Inc. The authors of the report have elaborately profiled the players in order to provide a sound understanding of how the competitive landscape could shape in the near future. Readers have been anticipated to become familiar with future competitive scenarios and prepare beforehand for any prospective …

Google News / Healthcare

Erythropoietin Drugs Market to Register Substantial Expansion by 2025

June 14, 2018 - by Nitin

The global Erythropoietin Drugs Market has been projected in a report by Transparency Market Research (TMR) to witness a rising focus on product development adopted by prominent companies operating in the industry. Players could be persuaded to search for new distributors due to the escalating level of competition in the market. For the purpose of earning an improved return of investment (ROI), players have been predicted to set their focus on tactical acquisitions while mainly aiming to up their production of erythropoietin drugs. Governments offering incentives for research on chronic ailments could give a strong uplift to players in terms …

Google News / Healthcare

Pain Management Therapeutics Market to Reflect Impressive Growth Rate by 2025

June 14, 2018 - by Nitin

The global Pain Management Therapeutics Market is extremely fragmented with both large and small players in high numbers. The degree of competition is high, but is not expected to deter new players from entering into the market on account of the high growth potential of the global pain management therapeutics market, states Transparency Market Research (TMR) in its new report based on this market. The report further states that regional players are intensifying the competition level by manufacturing a large volume of pain management drugs and at cheaper costs as compared to well-established and well-known manufacturers. Nevertheless, the well-established players …

Google News / Healthcare

Oncology Biosimilars Market is Expected to Expand at an Impressive Rate by 2025

June 14, 2018 - by Nitin

Transparency Market Research (TMR) in one of its latest publications envisages the global Oncology Biosimilars Market to feature a fairly consolidated vendor landscape. Prominent participants in the market are vying to enter into strategic collaborations to strengthen financial standing as well to expand global outreach. For instance, Dr. Reddy’s Laboratories entered into an agreement with TR-Pharm to be a win-win for both the companies. As per the agreement, TR-Pharm will commercialize Dr.Reddy’s three biosimilars in Turkey to translate into business growth for the former. On the other hand, Dr.Reddy’s Laboratories is benefitted with the goodwill of a regional player for …

Google News / Healthcare

Ophthalmic Drugs Market to Witness an Outstanding Growth by 2025

June 14, 2018 - by Nitin

Some of the key players operating in the global Ophthalmic Drugs Market are ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd. Novartis, of them, is a leading player, which held a share of 12% in the market in 2012. Noticeable trends in the global ophthalmic drugs market are keen players entering into co-development agreements to formulate novel biological agents having lesser treatment durations, emerging market players focusing on unmet medical needs in ophthalmology, and generic manufacturers bolstering their distribution networks of affordable …